CompletedPHASE1, PHASE2NCT00776503
Vorinostat and Low Dose Cytarabine for High Risk Myelodysplasia
Studying C syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Groupe Francophone des Myelodysplasies
- Principal Investigator
- Thomas PREBET, MDGroupe Francophone des Myelodysplasies
- Intervention
- VORINOSTAT(drug)
- Enrollment
- 52 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2008 – 2011
Study locations (14)
- Hôpital de la Durance, Avignon, France
- Hopital Avicenne, Bobigny, France
- CH René Dubos, Cergy-Pontoise, France
- Hematology Dpt, Hôpital Sud Francilien, Corbeil-Essonnes, France
- CHU Grenoble, Grenoble, France
- Hôpital Edouard Heriot, dpt Hématologie Clinique, Lyon, France
- Hematology Dpt, Institut Paoli Calmettes, Marseille, France
- Hematology Dpt, Hopital de l'Hotel Dieu, Nantes, France
- Hematology Dpt, Hopital Saint Louis, Paris, France
- Hematology Dpt, Hopital Cochin, Paris, France
- Centre Henri Bequerel, Rouen, France
- Centre René Huguenin, Saint-Cloud, France
- Hematology Dpt, Hopital Haute Pierre, Strasbourg, France
- Hematology Dpt, Hopital Purpan, Toulouse, France
Collaborators
Merck Sharp & Dohme LLC
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00776503 on ClinicalTrials.govOther trials for C syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07283900Ascorbate in Myelodysplastic SyndromePrajwal Dhakal
- RECRUITINGPHASE2NCT07505745MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/ObesityHudson Biotech
- RECRUITINGPHASE2, PHASE3NCT06694740Effect of Interferon Gamma as a Treatment for Post-aggressive Immunosuppression in Intensive Care Units, a Randomized Bayesian Double-blind Controlled Trial Versus PlaceboAssistance Publique - Hôpitaux de Paris
- RECRUITINGPHASE4NCT06865885LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL LoweringUniversity of California, San Diego
- ACTIVE NOT RECRUITINGNCT06797609Comparing the Performance of Serum Creatinine and Cystatin C-based GFR Estimations in Predicting Directly Measured GFR in Patients With or Without Nephrotic SyndromeMario Negri Institute for Pharmacological Research
- RECRUITINGNANCT06528639A Clinical Study on Exercise Guided by CPET to Reduce the Risk of Metabolic Cardiovascular Diseases（C-MET Trial）Peking University Third Hospital
- ACTIVE NOT RECRUITINGNANCT05497388Efficacy of Serious Game Interventions on HCV Education for HIV PatientsNational Taiwan University Hospital
- RECRUITINGNANCT05390424Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood SpotUniversity Hospital, Rouen